Relaxin-3: Difference between revisions
CSV import |
CSV import |
||
| Line 24: | Line 24: | ||
{{neuroscience-stub}} | {{neuroscience-stub}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
== Relaxin-3 gallery == | |||
<gallery> | |||
File:Relaxin-3 structure.jpg|Relaxin-3 structure | |||
File:Relaxin3 in the NI.jpg|Relaxin-3 in the NI | |||
File:Distribution of relaxin-3-positive neurons and projections.jpg|Distribution of relaxin-3-positive neurons and projections | |||
</gallery> | |||
Latest revision as of 05:58, 3 March 2025
Relaxin-3 is a neuropeptide that belongs to the relaxin/insulin family. It was discovered in the early 2000s and is primarily found in the brain, specifically in the nucleus incertus of the brainstem. Relaxin-3 is involved in a variety of physiological processes, including stress response, feeding behavior, and circadian rhythm regulation.
Structure[edit]
Relaxin-3 is a peptide hormone, meaning it is composed of amino acids. It has a similar structure to insulin, with two chains (A and B) connected by disulfide bonds. The A-chain contains 24 amino acids, while the B-chain contains 29. This structure is conserved across many species, suggesting it plays a crucial role in the function of the hormone.
Function[edit]
Relaxin-3 is primarily expressed in the nucleus incertus of the brainstem, a region involved in stress response and arousal. It is also found in other areas of the brain, including the hypothalamus and hippocampus.
Relaxin-3 has been shown to play a role in several physiological processes. It is involved in the regulation of feeding behavior, with studies showing that it can stimulate food intake. It also plays a role in the stress response, with increased levels of relaxin-3 observed in response to stress. Additionally, relaxin-3 is involved in the regulation of circadian rhythms, the body's internal clock.
Clinical significance[edit]
Due to its role in stress response and feeding behavior, relaxin-3 has been implicated in several disorders, including anxiety disorders, depression, and obesity. Studies have shown that blocking the action of relaxin-3 can reduce anxiety-like behavior in animal models, suggesting it may be a potential target for the treatment of anxiety disorders. Similarly, because of its role in stimulating food intake, relaxin-3 may be a potential target for the treatment of obesity.
See also[edit]

This article is a neuroscience stub. You can help WikiMD by expanding it!
Relaxin-3 gallery[edit]
-
Relaxin-3 structure
-
Relaxin-3 in the NI
-
Distribution of relaxin-3-positive neurons and projections
